Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Colorectal Neoplasms 6 Biliary Tract Neoplasms 5 Sarcoma 3 Rectal Neoplasms 3 Colonic Neoplasms 3 Advanced or Metastatic Solid Tumors 3 Uterine Cervical Neoplasms 2 Solid Tumors 2 Nasopharyngeal Carcinoma 2 Gastrointestinal Stromal Tumors 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Thymoma 1 Stomach Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Rare Tumour 1 Prostatic Neoplasms 1 Piebaldism 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Multiple Primary 1 Neoplasm Metastasis 1 NSCLC 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Locally Advanced Rectal Carcinoma 1 Histiocytoma, Malignant Fibrous 1

Interventions

Injections 26 toripalimab 17 pembrolizumab 17 tislelizumab 12 Gemcitabine 8 Cisplatin 7 spartalizumab 6 atezolizumab 6 Irinotecan 6 Carboplatin 6 Paclitaxel 5 Oxaliplatin 5 Nivolumab 5 Leucovorin 5 Fluorouracil 5 camrelizumab 4 Pemetrexed 4 Docetaxel 4 Cetuximab 4 Capecitabine 4 trastuzumab deruxtecan 3 sintilimab 3 olaparib 3 lenvatinib 3 cediranib 3 PM 01183 3 Drug Therapy 3 Cyclophosphamide 3 Bevacizumab 3 Albumin-Bound Paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × envafolimab × Clear all

NCT07562347 2026-05-01

ENCOMPASS STUD

IR INNOVATE RESEARCH PRIVATE LIMITED

Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡